| Literature DB >> 30643250 |
Vinayak Bhandari1,2, Christianne Hoey1,3, Lydia Y Liu1,2, Emilie Lalonde1,2, Jessica Ray1,3, Julie Livingstone2, Robert Lesurf2, Yu-Jia Shiah2, Tina Vujcic3, Xiaoyong Huang3, Shadrielle M G Espiritu2, Lawrence E Heisler2, Fouad Yousif2, Vincent Huang2, Takafumi N Yamaguchi2, Cindy Q Yao2, Veronica Y Sabelnykova2, Michael Fraser2, Melvin L K Chua4,5, Theodorus van der Kwast6, Stanley K Liu1,3,7, Paul C Boutros8,9,10,11,12,13,14, Robert G Bristow15,16,17,18,19,20.
Abstract
Many primary-tumor subregions have low levels of molecular oxygen, termed hypoxia. Hypoxic tumors are at elevated risk for local failure and distant metastasis, but the molecular hallmarks of tumor hypoxia remain poorly defined. To fill this gap, we quantified hypoxia in 8,006 tumors across 19 tumor types. In ten tumor types, hypoxia was associated with elevated genomic instability. In all 19 tumor types, hypoxic tumors exhibited characteristic driver-mutation signatures. We observed widespread hypoxia-associated dysregulation of microRNAs (miRNAs) across cancers and functionally validated miR-133a-3p as a hypoxia-modulated miRNA. In localized prostate cancer, hypoxia was associated with elevated rates of chromothripsis, allelic loss of PTEN and shorter telomeres. These associations are particularly enriched in polyclonal tumors, representing a constellation of features resembling tumor nimbosus, an aggressive cellular phenotype. Overall, this work establishes that tumor hypoxia may drive aggressive molecular features across cancers and shape the clinical trajectory of individual tumors.Entities:
Mesh:
Substances:
Year: 2019 PMID: 30643250 DOI: 10.1038/s41588-018-0318-2
Source DB: PubMed Journal: Nat Genet ISSN: 1061-4036 Impact factor: 38.330